By Colin KellaherHoth Therapeutics on Friday said it has ended plans to combine with privately held Algorithm Sciences in a reverse merger. Hoth, a New York biopharmaceutical company, said the companies determined that they couldn't reach a definitive agreement and that it was their best interests to continue to operate separately.

Source: Wall Street Journal May 12, 2023 20:19 UTC